Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although individuals infected with Delta are at risk of developing severe lung disease, infection with Omicron often causes milder symptoms, especially in vaccinated individuals(1,2). The question arises of whether widespread Om...

Descripción completa

Detalles Bibliográficos
Autores principales: Suryawanshi, Rahul K., Chen, Irene P., Ma, Tongcui, Syed, Abdullah M., Brazer, Noah, Saldhi, Prachi, Simoneau, Camille R., Ciling, Alison, Khalid, Mir M., Sreekumar, Bharath, Chen, Pei-Yi, Kumar, G. Renuka, Montano, Mauricio, Gascon, Ronne, Tsou, Chia-Lin, Garcia-Knight, Miguel A., Sotomayor-Gonzalez, Alicia, Servellita, Venice, Gliwa, Amelia, Nguyen, Jenny, Silva, Ines, Milbes, Bilal, Kojima, Noah, Hess, Victoria, Shacreaw, Maria, Lopez, Lauren, Brobeck, Matthew, Turner, Fred, Soveg, Frank W., George, Ashley F., Fang, Xiaohui, Maishan, Mazharul, Matthay, Michael, Morris, Mary Kate, Wadford, Debra, Hanson, Carl, Greene, Warner C., Andino, Raul, Spraggon, Lee, Roan, Nadia R., Chiu, Charles Y., Doudna, Jennifer A., Ott, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279157/
https://www.ncbi.nlm.nih.gov/pubmed/35584773
http://dx.doi.org/10.1038/s41586-022-04865-0

Ejemplares similares

Ejemplares similares